DeepGene damage signature
SyntheticSynthetic demo data2 samples: baseline day 0 · retest day 90
Damage score · retest day 90
64/100
vs baseline (day 0)
-20
8 improved · 2 worsened
synthetic signature · consistent with this patient's biology
- 4 opportunists above range: Escherichia coli, Enterococcus faecium, Streptococcus gallolyticus
- 4 keystone species absent
- Shannon 2.48 (expected ≥ 3)
- 7 resistance genes
- Tissue recycling index 44
Pathogens / opportunists4/5
↑ from 3
Keystone species4/8
Diversity1/2
↓ from 2
Metabolic modules1/4
Vitamin synthesis3/7
↓ from 4
Oral translocation1/1
Host DNA0/1
↓ from 1
Tissue recycling1/1
Central mechanisms0/2
↓ from 2
Virulence factors4/4
Antibiotic resistance genes7/7
↓ from 8
Genetic predisposition2/2
Opportunists above range
Escherichia coli 21.984% AR
Enterococcus faecium 10.992% AR
Streptococcus gallolyticus 2.198% AR
Clostridioides difficile 2.198% AR
Keystone species absent
Akkermansia muciniphila, Bifidobacterium longum, Butyricicoccus pullicaecorum, Eubacterium rectale
Capacity
Shannon 2.48 · butyrate 541 CPM · SCFA 854
H2S above band
3 vitamins below
Host & mechanisms
tissue recycling 44/100
oral translocation 5% AR
7 resistance genes · 4 virulence factors
Import a sample
A baseline sample re-initializes this patient's microbiome, pathways and predispositions from the measurement; a retest adds a comparison and updates them. Every theory, steering gain and dietary sensitivity downstream is then conditioned on the measured signature.
All elements · baseline → latest
Value, status vs the expected range, and the implication on health. Changes coloured: green improved / resolved, red worsened / new.
Pathogens / opportunists · 5
| Escherichia coli | 0.703 % AR · in range | 21.984 % AR · above range(worsened) | expected <= 1% | In excess raises LPS load and zonulin release, opening tight junctions. |
| Klebsiella pneumoniae | 6.971 % AR · above range | 0.216 % AR · in range(improved) | expected <= 0.3% | Opportunist above range; relevant after antibiotics and in inflammation. |
| Enterococcus faecium | 0.116 % AR · in range | 10.992 % AR · above range(worsened) | expected <= 0.5% | Opportunist above range; relevant after antibiotics and in inflammation. |
| Streptococcus gallolyticus | 2.324 % AR · above range | 2.198 % AR · above range | expected <= 0.1% | Opportunist above range; relevant after antibiotics and in inflammation. |
| Clostridioides difficile | 2.324 % AR · above range | 2.198 % AR · above range | expected <= 0.1% | Opportunist above range; relevant after antibiotics and in inflammation. |
Keystone species · 8
| Akkermansia muciniphila | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Bifidobacterium longum | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Butyricicoccus pullicaecorum | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Eubacterium rectale | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Faecalibacterium prausnitzii | 1.15 % AR · in range | 0.57 % AR · in range | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Lactobacillus species | 0.22 % AR · in range | 1.44 % AR · in range | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Roseburia intestinalis | 1.03 % AR · in range | 0.2 % AR · in range | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Ruminococcus bromii | 0.1 % AR · in range | 1.13 % AR · in range | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
Diversity · 2
| indice Shannon | 2.26 · below range | 2.48 · below range | expected >= 3.0 | Low diversity: fewer reserve metabolic routes, slower recovery after perturbation. |
| numar de specii detectate | 85 specii · below range | 100 specii · in range(improved) | expected >= 100 | Species count below reference. |
Metabolic modules · 4
| Butyrate production | 487 CPM · in range | 541 CPM · in range | expected 255.83-1089.91 CPM | Butyrate is the main colonocyte fuel and barrier signal. |
| Short Chain Fatty Acid Production | 825 CPM · in range | 854 CPM · in range | expected 535.03-1572.59 CPM | Total SCFA capacity. |
| GABA production | 257 CPM · in range | 262 CPM · in range | expected 87.31-766.53 CPM | Gut–brain axis capacity. |
| H2S production (sulfate reduction) | 302 CPM · above range | 373 CPM · above range | expected banda de referinta | Hydrogen sulfide above band irritates the mucosa. |
Vitamin synthesis · 7
| Vitamin B1 - Thiamin | 532 CPM · below range | 516 CPM · below range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B2 - Riboflavin | 282 CPM · below range | 308 CPM · below range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B5 - Pantothenic acid | 223 CPM · below range | 251 CPM · below range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B6 - Pyridoxine | 278 CPM · below range | 3467 CPM · in range(improved) | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B7 - Biotin | 3631 CPM · in range | 4204 CPM · in range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B9 - Folate | 4078 CPM · in range | 3898 CPM · in range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B12 - Cobalamin | 3071 CPM · in range | 3558 CPM · in range | expected 2000-5000 CPM | Microbial synthesis capacity. |
Oral translocation · 1
| Translocare orala (indice) | 5.28 % AR · above range | 5 % AR · above range | expected <= 2% | Oral taxa in stool: reduced gastric barrier or dysbiosis. |
Host DNA · 1
| fragmentare mixta | 202 pb · atypical | 165 pb · in range(improved) | expected 150-170 pb | Host cell-free DNA fragmentation pattern. |
Tissue recycling · 1
| indice de reciclare tisulara | 44 /100 · above range | 44 /100 · above range | expected < 35 | Epithelial turnover. |
Central mechanisms · 2
| molecular_mimicry | 70 /100 · above range | 64 /100 · in range(improved) | expected < 65 | Cross-reactive antigen load. |
| estrobolome | 68 /100 · above range | 65 /100 · in range(improved) | expected < 65 | Estrogen-recycling capacity. |
Species dominance · 1
| Escherichia coli | 27.11 % AR · above range | resolved(resolved) | expected < 20% per specie | One species occupies the niche of others. |
Virulence factors · 4
| fimD outer membrane usher | 93 potriviri/M · present | 97 potriviri/M · present | expected absent | Virulence factor detected. |
| chuA heme/hemoglobin receptor | 41 potriviri/M · present | 75 potriviri/M · present | expected absent | Virulence factor detected. |
| irp2 yersiniabactin synthetase | 39 potriviri/M · present | 90 potriviri/M · present | expected absent | Virulence factor detected. |
| espX4 type III secretion | 24 potriviri/M · present | 98 potriviri/M · present | expected absent | Virulence factor detected. |
Antibiotic resistance genes · 8
| sul1 | 1.6 citiri/M · present | 9.6 citiri/M · present | expected nedetectat | Resistance gene detected. |
| sul2 | 2.8 citiri/M · present | 10.8 citiri/M · present | expected nedetectat | Resistance gene detected. |
| tet(O/M/O) | 6 citiri/M · present | 9.6 citiri/M · present | expected nedetectat | Resistance gene detected. |
| Ecol_ampC_BLA | 10.1 citiri/M · present | 4.4 citiri/M · present | expected nedetectat | Resistance gene detected. |
| aadA | 10 citiri/M · present | 8.1 citiri/M · present | expected nedetectat | Resistance gene detected. |
| dfrA1 | 11 citiri/M · present | 8.2 citiri/M · present | expected nedetectat | Resistance gene detected. |
| APH(6)-Id | 4.5 citiri/M · present | 3.7 citiri/M · present | expected nedetectat | Resistance gene detected. |
| Erm(49) | 2.6 citiri/M · present | resolved(resolved) | expected nedetectat | Resistance gene detected. |
Genetic predisposition · 2
| FUT2 | 2.96 OR · risk variant | 2.88 OR · risk variant | expected reference genotype | Reduced mucosal fucosylation |
| IL6 | 3.2 OR · risk variant | 2.06 OR · risk variant | expected reference genotype | Higher inflammatory tone |